Peter Vink

2.3k total citations
34 papers, 1.5k citations indexed

About

Peter Vink is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Peter Vink has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 14 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Peter Vink's work include HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers) and Pneumonia and Respiratory Infections (8 papers). Peter Vink is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV Research and Treatment (8 papers) and Pneumonia and Respiratory Infections (8 papers). Peter Vink collaborates with scholars based in United States, Belgium and Canada. Peter Vink's co-authors include John Farley, James C. King, Loran T. Clement, Grace Bradley, Paul Palumbo, Elaine J. Abrams, E. Richard Stiehm, Richard Lichenstein, Marc Bulterys and Joanne M. Langley and has published in prestigious journals such as The Journal of Immunology, PEDIATRICS and Clinical Infectious Diseases.

In The Last Decade

Peter Vink

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Vink United States 22 754 686 329 293 209 34 1.5k
Marilyn J. Crain United States 24 1.1k 1.5× 640 0.9× 246 0.7× 374 1.3× 236 1.1× 48 1.9k
Raffaele Malinverni Switzerland 22 1.0k 1.4× 648 0.9× 288 0.9× 97 0.3× 153 0.7× 36 1.7k
James Riddell United States 25 707 0.9× 707 1.0× 436 1.3× 157 0.5× 210 1.0× 72 1.9k
Melissa Krone United States 17 566 0.8× 872 1.3× 862 2.6× 182 0.6× 382 1.8× 25 1.7k
Jean‐Louis Vildé France 18 1.0k 1.3× 513 0.7× 372 1.1× 230 0.8× 88 0.4× 32 1.7k
Neil Bodsworth Australia 22 978 1.3× 396 0.6× 164 0.5× 77 0.3× 69 0.3× 40 1.5k
Susan Bersoff‐Matcha United States 13 305 0.4× 523 0.8× 158 0.5× 141 0.5× 61 0.3× 21 1.1k
Jos Bogaerts Rwanda 15 488 0.6× 430 0.6× 180 0.5× 96 0.3× 89 0.4× 16 1.1k
F. Raffi France 21 734 1.0× 721 1.1× 220 0.7× 91 0.3× 69 0.3× 71 1.5k
Jeffrey P. Nadler United States 14 632 0.8× 1.1k 1.6× 1.0k 3.1× 132 0.5× 240 1.1× 28 1.9k

Countries citing papers authored by Peter Vink

Since Specialization
Citations

This map shows the geographic impact of Peter Vink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Vink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Vink more than expected).

Fields of papers citing papers by Peter Vink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Vink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Vink. The network helps show where Peter Vink may publish in the future.

Co-authorship network of co-authors of Peter Vink

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Vink. A scholar is included among the top collaborators of Peter Vink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Vink. Peter Vink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sullivan, Keith M., Francis A. Farraye, Kevin Winthrop, et al.. (2022). Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine. 41(1). 36–48. 16 indexed citations
2.
Dagnew, Alemnew F., Peter Vink, Mamadou Dramé, et al.. (2021). Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview. Human Vaccines & Immunotherapeutics. 17(11). 4132–4143. 11 indexed citations
3.
4.
McNeil, Shelly, Scott A. Halperin, Joanne M. Langley, et al.. (2005). Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers. Clinical Infectious Diseases. 41(8). 1114–1122. 232 indexed citations
5.
Abrams, Elaine J., Jeffrey Wiener, Louise Kuhn, et al.. (2003). Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children. AIDS. 17(6). 867–877. 61 indexed citations
6.
Nesheim, Steven R., Paul Palumbo, Kevin M. Sullivan, et al.. (2003). Quantitative RNA Testing for Diagnosis of HIV-Infected Infants. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(2). 192–195. 41 indexed citations
7.
Nachman, Sharon, Soyeon Kim, James C. King, et al.. (2003). Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection. PEDIATRICS. 112(1). 66–73. 59 indexed citations
8.
Orloff, Sherry L., Marc Bulterys, Peter Vink, et al.. (2001). Maternal Characteristics Associated With Antenatal, Intrapartum, and Neonatal Zidovudine Use in Four U.S. Cities, 1994–1998. JAIDS Journal of Acquired Immune Deficiency Syndromes. 28(1). 65–72. 10 indexed citations
9.
Palumbo, Paul, Bart Holland, Trudy Dobbs, et al.. (2001). Antiretroviral Resistance Mutations among Pregnant Human Immunodeficiency Virus Type 1–Infected Women and Their Newborns in the United States: Vertical Transmission and Clades. The Journal of Infectious Diseases. 184(9). 1120–1126. 45 indexed citations
10.
Kuhn, Louise, Elaine J. Abrams, Jeremy Weedon, et al.. (2000). Disease Progression and Early Viral Dynamics in Human Immunodeficiency Virus–Infected Children Exposed to Zidovudine during Prenatal and Perinatal Periods. The Journal of Infectious Diseases. 182(1). 104–111. 24 indexed citations
11.
Nahmias, André J., W. Scott Clark, Athena P. Kourtis, et al.. (1998). Thymic Dysfunction and Time of Infection Predict Mortality in Human Immunodeficiency Virus‐Infected Infants. The Journal of Infectious Diseases. 178(3). 680–685. 47 indexed citations
12.
Lichenstein, Richard, et al.. (1998). Bacteremia in febrile human immunodeficiency virus-infected children presenting to ambulatory care settings. The Pediatric Infectious Disease Journal. 17(5). 381–385. 7 indexed citations
13.
Greenberg, Barbara, Richard D. Semba, Peter Vink, et al.. (1997). Vitamin A deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS. 11(3). 325–332. 66 indexed citations
14.
King, James C., Peter Vink, John Farley, et al.. (1996). Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children. The Pediatric Infectious Disease Journal. 15(3). 192–196. 69 indexed citations
15.
16.
Nesheim, Steven R., Nathan Shaffer, Peter Vink, et al.. (1996). Lack of increased risk for perinatal human immunodeficiency virus transmission to subsequent children born to infected women. The Pediatric Infectious Disease Journal. 15(10). 886–890. 8 indexed citations
17.
Kale, K. V., James C. King, John Farley, et al.. (1995). The immunogenicity of Haemophilus influenzae type b conjugate (HbOC) vaccine in human immunodeficiency virus-infected and uninfected infants. The Pediatric Infectious Disease Journal. 14(5). 350–353. 24 indexed citations
18.
Farley, John, James C. King, Prasanna Nair, et al.. (1994). Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection. The Journal of Pediatrics. 124(6). 853–858. 56 indexed citations
19.
Clement, Loran T., Peter Vink, & Grace Bradley. (1990). Novel immunoregulatory functions of phenotypically distinct subpopulations of CD4+ cells in the human neonate.. The Journal of Immunology. 145(1). 102–108. 121 indexed citations
20.
Stein, Evan A., et al.. (1981). Repetitive intermittent flow plasma exchange in patients with severe hypercholesterolemia. Atherosclerosis. 38(1-2). 149–164. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marilyn J. Crain Breakdown of academic impact, for papers by Raffaele Malinverni Breakdown of academic impact, for papers by James Riddell Breakdown of academic impact, for papers by Melissa Krone Breakdown of academic impact, for papers by Jean‐Louis Vildé Breakdown of academic impact, for papers by Neil Bodsworth Breakdown of academic impact, for papers by Susan Bersoff‐Matcha Breakdown of academic impact, for papers by Jos Bogaerts Breakdown of academic impact, for papers by F. Raffi Breakdown of academic impact, for papers by Jeffrey P. Nadler
Rankless by CCL
2026